Unlocking Novel Biology & Rational Design to Develop Potent, Selective & Safer Molecular Glues Cures Against Cancer & Beyond
From Revolution Medicines' landmark FDA approval of RASONQUE™ to major discovery partnerships such as the up to $1.4 billion Novartis-Orionis collaboration, molecular glues continue to generate momentum across both clinical development and early-stage innovation. Combined with rapid advances in artificial intelligence, automation, structural biology, and induced proximity therapeutics, the field is entering a new era of discovery, unlocking previously inaccessible biology and expanding the potential of molecular glues across a growing range of disease areas.
As investment, scientific understanding, and translational success accelerate, the 5th Molecular Glue Drug Development Summit serves as the industry's only dedicated forum bringing together the scientists and drug developers advancing molecular glue therapeutics from early discovery through translational and clinical development.
This summit is the one forum that convenes pharma, biotech, and academia to tackle exactly those questions, from glueability and next-generation screening to translational and clinical success. I'm looking forward to exchanging ideas with this community and helping shape the next wave of induced-proximity medicines
Ajinkya Patil, Principal Scientist, Pfizer
Summits such as this are critical to help the field advance even faster as they offer opportunities to learn from these experts who are immersed in the field. I’m looking forward to several days of exciting science and strategic discussions around molecular glues
Scott Edmondson, Senior Vice President, Chemistry, Nimbus Therapeutics
I look forward to this summit as a unique forum to exchange ideas across chemical biology, structural biology, drug discovery, and translation, and to explore how molecular glues can unlock new therapeutic mechanisms beyond degradation
Evripidis Gavathiotis, Professor of Biochemistry and of Medicine, Albert Einstein College of Medicine
Explore the Full Event Guide
- Get the complete agenda, speaker faculty, workshops, and networking opportunities in one place
- Explore the latest advances in molecular glue therapeutics, induced proximity biology, targeted protein degradation, and protein stabilization
- Discover how AI, computational modelling, automation, and structural biology are transforming rational glue discovery
- See which pharma, biotech, academic, and investment leaders are driving the next wave of proximity-based therapeutics
- Share with colleagues to evaluate scientific learnings, partnership opportunities, and commercial potential
Speakers Included:
Attending Companies Include
Explore Related Events
Explore the Agenda
Discover the latest advances in molecular glue therapeutics, induced proximity biology, AI-enabled drug discovery, targeted protein degradation, and translational development.
Partner With Us
Showcase your platform, technology, or services to the pharma, biotech, and academic leaders advancing next-generation molecular glue medicines.
Join Industry Leaders
Connect with the scientists, drug developers, investors, and decision-makers shaping the future of induced proximity therapeutics.